New Drug Approvals Highlight AJPB Week in Review

Article

Top stories of the week on The American Journal of Pharmacy Benefits.

Recent Videos
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
male pharmacist using digital tablet during inventory in pharmacy | Image Credit: sofiko14 - stock.adobe.com
Related Content
Image Credit: ralwel - stock.adobe.com

FDA Approves Ocrevus Zunovo for 2 Forms of Multiple Sclerosis

Ashley Gallagher, Associate Editor
September 13th 2024
Article
Pharmacy Focus: World Psychedelics Day

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
June 14th 2024
Podcast
Image Credit: lexiconimages - stock.adobe.com

Non-Medical Switch to Infliximab Biosimilar Demonstrates Similar Outcomes for IBD

Ashley Gallagher, Associate Editor
September 12th 2024
Article
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

January 25th 2024
Podcast
Pharmacy Rare Disease, Orphan Drug | Image Credit: Jacob Lund - stock.adobe.com

FDA Grants Orphan Drug Designation to AISA-021 for Systemic Sclerosis

Ashley Gallagher, Associate Editor
September 11th 2024
Article
FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome

FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome

Aislinn Antrim, Assistant Managing Editor
September 11th 2024
Article